Kolb K W, Garnett W R, Small R E, Vetrovec G W, Kline B J, Fox T
Ther Drug Monit. 1984;6(3):306-12. doi: 10.1097/00007691-198409000-00009.
Cimetidine has been reported to inhibit the hepatic metabolism of numerous drugs. Theoretically cimetidine could inhibit the metabolism of quinidine. This study was undertaken to determine the effect of cimetidine on quinidine plasma concentrations. Nine healthy volunteers were entered into the matched-pairs study. Baseline quinidine pharmacokinetic parameters were determined after a single oral 400-mg dose. Study parameters were determined after 3 days of cimetidine 300 mg p.o. q.i.d., when 400 mg quinidine was again administered. Cimetidine increased the area under the time-concentration curve (14.5%, p less than 0.01), decreased the total body clearance (24.9%, p less than 0.05), and prolonged the half-life (22.6%, p less than 0.05) of quinidine in this study. There was no change in peak quinidine concentrations or time to peak. These data document an interaction between cimetidine and quinidine. The clinical importance of this interaction should be greatest in patients with impaired liver function, patients with preexisting near-toxic plasma concentrations of quinidine, and the elderly. Patients placed on cimetidine and quinidine should be monitored closely for signs and symptoms of quinidine toxicity.
据报道,西咪替丁可抑制多种药物的肝脏代谢。理论上,西咪替丁可能会抑制奎尼丁的代谢。本研究旨在确定西咪替丁对奎尼丁血药浓度的影响。九名健康志愿者参与了配对研究。在单次口服400毫克剂量后测定基线奎尼丁药代动力学参数。在口服西咪替丁300毫克每日四次,持续3天后再次给予400毫克奎尼丁时,测定研究参数。在本研究中,西咪替丁增加了时间-浓度曲线下面积(14.5%,p<0.01),降低了总体清除率(24.9%,p<0.05),并延长了奎尼丁的半衰期(22.6%,p<0.05)。奎尼丁的峰值浓度或达峰时间没有变化。这些数据证明了西咪替丁与奎尼丁之间存在相互作用。这种相互作用的临床重要性在肝功能受损的患者、已有接近中毒血药浓度的奎尼丁的患者以及老年人中可能最大。接受西咪替丁和奎尼丁治疗的患者应密切监测奎尼丁毒性的体征和症状。